Aktis Oncology $318 million IPO
This is the first biotech IPO of 2026
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
W. L. Gore & Associates acquisition of Conformal Medical
We are advising Gore on the transaction
GSK strategic collaboration with CAMP4 Therapeutics
We advised GSK on the transaction
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
GSK exclusive license agreement with Empirico
We advised GSK on the transaction
Turn Therapeutics direct listing
We advised Turn Therapeutics on its Nasdaq listing
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale
UST sale of HealthProof to Bain
We advised UST on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
GSK agreements with Hengrui Pharma to develop up to 12 innovative medicines
We are advising GSK on the transaction